This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | |
| Wikipedia page | https://en.wikipedia.org/wiki/Find |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 37 | 1,210,744 | 4,008,641 | -669,170 | 0 | 287,500 | 521,015 | 726,408 | 1,210,744 | 2,237,831 | 2,601,630 | 4,086,078 | 8,932,032 | 62,630,901 |
| Global health | 37 | 1,210,744 | 4,008,641 | -669,170 | 0 | 287,500 | 521,015 | 726,408 | 1,210,744 | 2,237,831 | 2,601,630 | 4,086,078 | 8,932,032 | 62,630,901 |
| Donor | Total | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 148,319,734.85 | 1,215,520.85 | 9,167,146.00 | 9,705,066.00 | 722,467.00 | 20,673,955.00 | 3,194,410.00 | 19,135,212.00 | 8,154,912.00 | 66,546,546.00 | 9,804,500.00 |
| Total | 148,319,734.85 | 1,215,520.85 | 9,167,146.00 | 9,705,066.00 | 722,467.00 | 20,673,955.00 | 3,194,410.00 | 19,135,212.00 | 8,154,912.00 | 66,546,546.00 | 9,804,500.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 37) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | 992,333.85 | 20 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to increase Human African Trypanosomiasis screening and treatment coverage in central Africa trans boundary areas; Aid type: Project-type interventions. Affected countries: Chad|Guinea|Uganda|Côte d'ivoire. | |
| Bill and Melinda Gates Foundation | 223,187.00 | 32 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop a comprehensive harmonized database validating genetic variations predictive of resistance to current and future Tuberculosis drug regimens; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 521,015.00 | 26 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to improve the effectiveness of public TB diagnostic services through the development and application of a methodology to map disease burden against diagnostic networks for TB; Aid type: Project-type interventions. Affected countries: Indonesia|Kenya. | |
| Bill and Melinda Gates Foundation | -54,065.00 | 35 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to provide product development expertise to a consortium of academic investigators to evaluate the performance of HIV incidence assays (CEPHIA-I), removing most of the management, coordination, and decision making activities off of their shoulders so that; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 232,282.00 | 31 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to evaluate the performance of the High Sensitive Rapid Diagnostic Test (HS-RDT) as compared to a Polymerase Chain Reaction (PCR) reference test in pregnant women attending antenatal care visits in malaria-endemic settings; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 798,399.00 | 22 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to increase Human African Trypanosomiasis screening and treatment coverage in central Africa trans boundary areas; Aid type: Project-type interventions. Affected countries: Chad|Guinea|Uganda|Côte d'ivoire. | |
| Bill and Melinda Gates Foundation | -37,468.00 | 34 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to determine the baseline limit of detection of Plasmodium Lactate Dehydrogenase-based Rapid Diagnostic Tests to guide the development of improved diagnostics to support malaria elimination in low-resource settings; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 37,468.00 | 33 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the collection, characterization and access to well characterized parasite specimens that are needed to support the development of new highly sensitive Rapid Diagnostic Tests (RDTs); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,499,347.00 | 13 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the development of diagnostic tests able to detect all malaria infections that cannot be detected today due to lack of sensitive tests; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,955,526.00 | 9 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to enable accelerated research and development of ground-breaking TB diagnostic tools that are suitable for use at lower levels of care in resource-limited countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 488,234.00 | 27 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to evaluate the performance of the High Sensitive Rapid Diagnostic Test (HS-RDT) as compared to a Polymerase Chain Reaction (PCR) reference test in pregnant women attending antenatal care visits in malaria-endemic settings; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 726,408.00 | 23 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to increase Human African Trypanosomiasis screening and treatment coverage in central Africa trans boundary areas; Aid type: Project-type interventions. Affected countries: Chad|Guinea|Uganda|Côte d'ivoire. | |
| Bill and Melinda Gates Foundation | 7,731,048.00 | 5 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to increase Human African Trypanosomiasis screening and treatment coverage in central Africa trans boundary areas; Aid type: Project-type interventions. Affected countries: Chad|Guinea|Uganda|Côte d'ivoire. | |
| Bill and Melinda Gates Foundation | 324,931.00 | 29 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | To enable accelerated research and development for new diagnostic tools that are suitable for use at the point-of-care (POC) in resource-limited endemic countries and can serve to diagnose patients who are currently difficult to diagnose (i.e. patients wh; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,210,744.00 | 19 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to lead efforts to drive successful uptake of diagnostic solutions suitable for different settings found in endemic countries, to address more effectively TB and other infectious diseases of poverty; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 438,343.00 | 28 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to determine the baseline limit of detection of Plasmodium Lactate Dehydrogenase-based Rapid Diagnostic Tests to guide the development of improved diagnostics to support malaria elimination in low-resource settings; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -669,170.00 | 37 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the late stage development of diagnostic tests for neglected infectious diseases such as tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 669,170.00 | 25 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop a comprehensive harmonized database validating genetic variations predictive of resistance to current and future Tuberculosis drug regimens; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 722,467.00 | 24 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to complete the demonstration and introduction of a new point-of-care, lateral flow, antibody detection diagnostic to be used to screen communities in the field for Human African Trypanosomiasis; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 3,533,447.00 | 11 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to provide product development expertise to a consortium of academic investigators to evaluate the performance of HIV incidence assays (CEPHIA-I), removing most of the management, coordination, and decision making activities off of their shoulders so that; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,237,831.00 | 15 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop a comprehensive harmonized database validating genetic variations predictive of resistance to current and future Tuberculosis drug regimens; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,086,078.00 | 8 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the collection, characterization and access to well characterized parasite specimens that are needed to support the development of new highly sensitive Rapid Diagnostic Tests (RDTs); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,884,567.00 | 17 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to complete the demonstration and introduction of a new point-of-care, lateral flow, antibody detection diagnostic to be used to screen communities in the field for Human African Trypanosomiasis; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 8,932,032.00 | 4 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | To enable accelerated research and development for new diagnostic tools that are suitable for use at the point-of-care (POC) in resource-limited endemic countries and can serve to diagnose patients who are currently difficult to diagnose (i.e. patients wh; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 287,500.00 | 30 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to complete the demonstration and introduction of a new point-of-care, lateral flow, antibody detection diagnostic to be used to screen communities in the field for Human African Trypanosomiasis; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 1,950,000.00 | 16 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to provide general operations support to FIND. FIND General Operating Support Grant. Investment start date: 11/5/2013 to end date: 4/30/2014. Grantee name: FIND; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 956,910.00 | 21 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to support the identification and validation of biomarkers for tuberculosis that could be used in diagnostic tests for point-of-care detection of disease or other indications toward improved care and control of tuberculosis in high-burden countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 11,799,022.00 | 2 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the late stage development of diagnostic tests for neglected infectious diseases such as tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 5,000,000.00 | 6 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide general operations support to FIND. FIND general operations support grant. Investment start date: 8/28/2012 to end date: 8/31/2013. Grantee name: FIND; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,601,630.00 | 12 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support a project to improve malaria patient care and disease control through the use of improved diagnostics; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | -265,440.00 | 36 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the late stage development of diagnostic tests for neglected infectious diseases such as tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,389,435.00 | 14 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to complete the demonstration and introduction of a new point-of-care, lateral flow, antibody detection diagnostic to be used to screen communities in the field for Human African Trypanosomiasis; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 1,435,615.00 | 18 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to support the identification and validation of biomarkers for tuberculosis that could be used in diagnostic tests for point-of-care detection of disease or other indications toward improved care and control of tuberculosis in high-burden countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,329,862.00 | 7 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the late stage development of diagnostic tests for neglected infectious diseases such as tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,915,645.00 | 10 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support mapping the distribution of Human African Trypanosomiasis. Mapping the Distribution of Human African Trypanosomiasis. Investment start date: 10/20/2007 to end date: 11/30/2011. Grantee name: FIND; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 62,630,901.00 | 1 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the late stage development of diagnostic tests for neglected infectious diseases such as tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 9,804,500.00 | 3 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support a project to improve malaria patient care and disease control through the use of improved diagnostics; Aid type: Project-type interventions. Affected regions: South of Sahara. |